AU2794199A - Thyroid hormone replacement using sustained release triiodothyronine - Google Patents
Thyroid hormone replacement using sustained release triiodothyronineInfo
- Publication number
- AU2794199A AU2794199A AU27941/99A AU2794199A AU2794199A AU 2794199 A AU2794199 A AU 2794199A AU 27941/99 A AU27941/99 A AU 27941/99A AU 2794199 A AU2794199 A AU 2794199A AU 2794199 A AU2794199 A AU 2794199A
- Authority
- AU
- Australia
- Prior art keywords
- triiodothyronine
- sustained release
- thyroid hormone
- hormone replacement
- replacement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 title 2
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
- 239000005495 thyroid hormone Substances 0.000 title 1
- 229940036555 thyroid hormone Drugs 0.000 title 1
- 229940035722 triiodothyronine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7609698P | 1998-02-26 | 1998-02-26 | |
US60076096 | 1998-02-26 | ||
US11732999P | 1999-01-22 | 1999-01-22 | |
US60117329 | 1999-01-22 | ||
PCT/US1999/004311 WO1999043307A1 (en) | 1998-02-26 | 1999-02-26 | Thyroid hormone replacement using sustained release triiodothyronine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2794199A true AU2794199A (en) | 1999-09-15 |
Family
ID=26757654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU27941/99A Abandoned AU2794199A (en) | 1998-02-26 | 1999-02-26 | Thyroid hormone replacement using sustained release triiodothyronine |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2794199A (en) |
WO (1) | WO1999043307A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0608402D0 (en) * | 2006-04-28 | 2006-06-07 | Diurnal Ltd | Thyroid treatment |
CN101511391B (en) | 2006-07-25 | 2013-03-13 | 利普生技术有限公司 | N-terminal polysialylation |
US20100136109A1 (en) * | 2007-04-23 | 2010-06-03 | Richard Ross | Sustained release |
US9968574B2 (en) * | 2009-05-15 | 2018-05-15 | The University Of Kentucky Research Foundation | Treatment of MCI and Alzheimer's disease |
CA2761298A1 (en) * | 2009-05-15 | 2010-11-18 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
US10188739B2 (en) | 2014-02-27 | 2019-01-29 | Xenetic Biosciences, Inc. | Compositions and methods for administering insulin or insulin-like protein to the brain |
US10695309B2 (en) | 2017-03-31 | 2020-06-30 | Western New England University | Sustained-release liothyronine formulations, method of preparation and method of use thereof |
US20230018014A1 (en) * | 2019-11-10 | 2023-01-19 | Pro-Al Medico-Technologies, Inc. | Novel compounds and formulations |
US20210196661A1 (en) * | 2019-12-30 | 2021-07-01 | Joseph Michael Abramowitz | Method for amelioration of insulin resistance |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
US3689669A (en) * | 1970-10-09 | 1972-09-05 | Univ Of North Carolina The | Antidepressant method and composition |
DK0550108T3 (en) * | 1991-12-30 | 1999-01-04 | Akzo Nobel Nv | Thyreoactive composition with long-term release |
-
1999
- 1999-02-26 AU AU27941/99A patent/AU2794199A/en not_active Abandoned
- 1999-02-26 WO PCT/US1999/004311 patent/WO1999043307A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999043307A1 (en) | 1999-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2338766B (en) | Release bearing | |
AU2546399A (en) | Preparations with controlled release | |
AUPP230698A0 (en) | Back support | |
AUPP252298A0 (en) | Document management software | |
AU3534599A (en) | Retaining arrangement for a rod member | |
GB2310860B (en) | Stable release agents | |
AU3438099A (en) | Error-recovery mechanism using a temporary forwarder in a wireless-atm network | |
AUPP725498A0 (en) | Back support improvement | |
AU6107698A (en) | Release mechanism | |
AU2794199A (en) | Thyroid hormone replacement using sustained release triiodothyronine | |
AUPP279698A0 (en) | Sustained release formulation | |
AU6220798A (en) | Release agent | |
GB2334486B (en) | Release unit | |
AU1100000A (en) | Compliance mechanism | |
AU6000498A (en) | Compounds for use in adept | |
AU1063699A (en) | Release compositions | |
AU5814498A (en) | Novel release latch - c-i-p | |
AU3543599A (en) | Receptors | |
AUPO956797A0 (en) | Quick release device | |
AU8743898A (en) | Pyramidal machine | |
AU6029298A (en) | Bioartificial hormone releasing device | |
GB9805008D0 (en) | Brake mechanism for rotator | |
AU4172099A (en) | Chelating agents | |
AU4501799A (en) | A new use for glycine | |
AU3621599A (en) | A file system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |